Skip to main content
Top

Open Access 20-04-2024 | Hodgkin Lymphoma

A pilot randomized controlled trial of an online intervention for Hodgkin lymphoma survivors to increase knowledge about late effects and recommended screening

Authors: Tara J. Rick, Smitha Sagaram, Patricia I. Jewett, Hee Yun Lee, Karim T. Sadak, Lucie M. Turcotte, Rachel I. Vogel, Anne Blaes

Published in: Journal of Cancer Survivorship

Login to get access

Abstract

Background

Hodgkin lymphoma (HL) survivors who received chest radiotherapy are at risk for breast cancer and cardiovascular disease, but screening adherence is low. We assessed the acceptability/feasibility of a web-based educational intervention and its impact on knowledge of health risks and screening.

Methods

HL survivors were randomized to either an interactive online educational intervention or handouts only. Surveys were completed at baseline and 3 months post-intervention. We described the acceptability/feasibility of the intervention and compared knowledge between groups.

Results

Fifty-two HL survivors participated; 27 in the intervention group and 25 in the control group. Eighteen (66%) intervention participants completed the intervention and reported high acceptability (89–100%). At baseline, adherence to breast cancer screening was low across all participants. Post-intervention, those in the intervention group more often than controls correctly identified breast cancer and echocardiogram screening guidelines (35% vs. 28%, P = 0.02 and 82% vs. 52%, P = 0.04) and reported knowing how to address potential complications from cancer treatments (87% vs. 64%, P = 0.03). We detected no increase in screening behavior post-intervention.

Conclusion

Online education modules for high-risk HL survivors are an acceptable method to improve knowledge of health risks and screening guidelines. Future interventions should focus on improving screening uptake in this population.

Implications for Cancer Survivors

Web-based learning can be useful in increasing cancer survivor knowledge of their unique risks and screening recommendations but does not necessarily change patient behavior. Involvement in a cancer survivorship program can help assess individual barriers and monitor uptake of screening.
Appendix
Available only for authorised users
Literature
11.
go back to reference Erin E. Hahn PhD, MPH, Yi-Lin Wu MS, Corrine E. Munoz-Plaza MPH, Jazmine Garcia Delgadillo MPH, Robert M. Cooper MD CRCP. Use of recommended posttreatment services for adolescent and young adult survivors of Hodgkin lymphoma. Cancer. 2019;125 Erin E. Hahn PhD, MPH, Yi-Lin Wu MS, Corrine E. Munoz-Plaza MPH, Jazmine Garcia Delgadillo MPH, Robert M. Cooper MD CRCP. Use of recommended posttreatment services for adolescent and young adult survivors of Hodgkin lymphoma. Cancer. 2019;125
17.
go back to reference Oeffinger KC, Ford JS, Moskowitz CS, Chou JF, Henderson TO, Hudson MM, Diller L, McDonald A, Ford J, Mubdi NZ, Rinehart D, Vukadinovich C, Gibson TM, Anderson N, Elkin EB, Garrett K, Rebull M, Leisenring W, Robison LL, Armstrong GT. Promoting breast cancer surveillance: the EMPOWER study, a randomized clinical trial in the childhood cancer survivor study. J Clin Oncol. 2019;37(24):2131–40.CrossRefPubMedPubMedCentral Oeffinger KC, Ford JS, Moskowitz CS, Chou JF, Henderson TO, Hudson MM, Diller L, McDonald A, Ford J, Mubdi NZ, Rinehart D, Vukadinovich C, Gibson TM, Anderson N, Elkin EB, Garrett K, Rebull M, Leisenring W, Robison LL, Armstrong GT. Promoting breast cancer surveillance: the EMPOWER study, a randomized clinical trial in the childhood cancer survivor study. J Clin Oncol. 2019;37(24):2131–40.CrossRefPubMedPubMedCentral
23.
24.
go back to reference Golsteijn RHJ, Bolman C, Volders E, Peels DA, De Vries H, Lechner L. Short-term efficacy of a computer-tailored physical activity intervention for prostate and colorectal cancer patients and survivors: a randomized controlled trial. Int J Behav Nutr Phys Act. 2018;15(1). https://doi.org/10.1186/S12966-018-0734-9 Golsteijn RHJ, Bolman C, Volders E, Peels DA, De Vries H, Lechner L. Short-term efficacy of a computer-tailored physical activity intervention for prostate and colorectal cancer patients and survivors: a randomized controlled trial. Int J Behav Nutr Phys Act. 2018;15(1). https://​doi.​org/​10.​1186/​S12966-018-0734-9
33.
35.
go back to reference Scanlon M, Blaes A, Geller M, Majhail NS, Lindgren B, Haddad T. Patient satisfaction with physician discussions of treatment impact on fertility, menopause and sexual health among pre-menopausal women with cancer. J Cancer. 2012;3(1). https://doi.org/10.7150/jca.4408 Scanlon M, Blaes A, Geller M, Majhail NS, Lindgren B, Haddad T. Patient satisfaction with physician discussions of treatment impact on fertility, menopause and sexual health among pre-menopausal women with cancer. J Cancer. 2012;3(1). https://​doi.​org/​10.​7150/​jca.​4408
37.
go back to reference Amweg LN, McReynolds J, Lansang K, Jones T, Snow C, Berry DL, Partridge AHUBML. Hodgkin lymphoma survivor wellness: development of a web-based intervention. Clin J Oncol Nurs. 2020;24(3):284–9.CrossRefPubMed Amweg LN, McReynolds J, Lansang K, Jones T, Snow C, Berry DL, Partridge AHUBML. Hodgkin lymphoma survivor wellness: development of a web-based intervention. Clin J Oncol Nurs. 2020;24(3):284–9.CrossRefPubMed
41.
go back to reference Nathan PC, Agha M, Pole JD, et al. Predictors of attendance at specialized survivor clinics in a population-based cohort of adult survivors of childhood cancer. J Cancer Surviv. 2016;10:611–8.CrossRefPubMed Nathan PC, Agha M, Pole JD, et al. Predictors of attendance at specialized survivor clinics in a population-based cohort of adult survivors of childhood cancer. J Cancer Surviv. 2016;10:611–8.CrossRefPubMed
Metadata
Title
A pilot randomized controlled trial of an online intervention for Hodgkin lymphoma survivors to increase knowledge about late effects and recommended screening
Authors
Tara J. Rick
Smitha Sagaram
Patricia I. Jewett
Hee Yun Lee
Karim T. Sadak
Lucie M. Turcotte
Rachel I. Vogel
Anne Blaes
Publication date
20-04-2024
Publisher
Springer US
Published in
Journal of Cancer Survivorship
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-024-01587-2
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine